Although the precise molecular mechanism underlying AHNAK involvement in β-adrenergic signalling remains to be determined, downregulation of AHNAK may be a new approach to increase the response to β-adrenergic stimulation and energy expenditure in adipose tissue, thereby treating obesity. This evidence concerns the gene AHNAK and obesity due to melanocortin 4 receptor deficiency.